Wafik El-Deiry: CD28 Bispecifics Enhance the Antitumor Activity of Trastuzumab Deruxtecan
Wafik El-Deiry/brown.edu

Wafik El-Deiry: CD28 Bispecifics Enhance the Antitumor Activity of Trastuzumab Deruxtecan

Wafik El-Deiry, former Associate Dean for Oncologic Sciences and Founding Director of the Cancer Center at Brown University, shared on LinkedIn:

“Nature Communications, online November 15, 2026. Boosting the immune system against cancer / drug combinations

‘Convert cytotoxic agents into drivers of durable antitumor immunity’

AI summary reviewed, edited and approved by Dr. El-Deiry:

‘The argument here is that chemotherapy and ADCs fail to generate durable immunity not because they are immunologically inert, but because nothing is in place to convert the killing into a T cell response.

Pairing the HER2-directed ADC trastuzumab deruxtecan with tumor-antigen-targeted CD28 bispecifics enhanced tumor rejection and produced durable memory in humanized mouse models of Tras-DXd-resistant disease, with comparable synergy from 5-fluorouracil – and it worked at lower or less frequent cytotoxic dosing, which is the toxicity argument.

Mechanistically the TAA×CD28 antibody drives expansion of clonally restricted tumor CD8+ T cells while the cytotoxic agent sustains that activation and preserves a naive/stem-like tumor-specific pool with a diversified TCR repertoire; notably the two cytotoxics act through separate innate routes, Tras-DXd expanding and activating conventional dendritic cells and 5-FU reprogramming suppressive myeloid cells toward an immunostimulatory state.

Humanized mouse models and an industry-funded study with patents filed; CD28 costimulatory bispecifics carry a known clinical history of cytokine-mediated toxicity that these models are not designed to reproduce.’ ”

Title: Cytotoxic drugs and bispecific T cell engagers synergize to rewire host immunity and elicit polyclonal antitumor T cell responses

Authors: Dylan Kwart, Qiaozhi Wei, Wei-Yi Cheng, Kamilah Ryan, Allen Leary, Jacquelynn Golubov, Ciara Torres, Patrick Poon, Jacqueline Warsaw, Jacob Lowy, Erica Ullman, Aynur Hermann, Jennifer Finney, Lauric Haber, Albert Canturri, Dharani Ajithdoss, Andria Skinner, Eric Smith, Christopher Daly, Jeremy Rabinowitz, Erin Paul, Nicole Stokes Oristian, William Poueymirou, Christina Adler, Min Ni, Namita T. Gupta, Frank Seebach, Melissa Mathias, Matthew Fury, Israel Lowy, William Olson, John C. Lin, Andrew Murphy, Bei Wang, Dimitris Skokos

Read the full article. 

You can also read:

Wafik El-Deiry: CD28 Bispecifics Enhance the Antitumor Activity of Trastuzumab Deruxtecan

Wafik El-Deiry: CD28 Bispecifics Enhance the Antitumor Activity of Trastuzumab Deruxtecan